Concepedia

Minori Koshiji

MK

Statistics

Publications

50

Citations

17.5K

H-Index

31

Active since

1997

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

National Cancer Center Hospital East

Aichi Cancer Center

Dana-Farber Cancer Institute

Sidney Kimmel Comprehensive Cancer Center

Minori Koshiji is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in oncology, medicine, and cancer immunotherapy.

Publications per year

1997–2017

50

Publications

50

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

Dung T. Le, Jennifer N. Uram, Hao Wang et al. · New England Journal of Medicine · 2015 · 9.4K citations · Full text

, , +17

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

Charles S. Fuchs, Jiří Tomášek, Filip Dumitru et al. · The Lancet · 2013 · 2.2K citations · Full text

, , +12

Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial

Kei Muro, Hyun Cheol Chung, Veena Shankaran et al. · The Lancet Oncology · 2016 · 1.1K citations · Full text

, , +12

Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan

Takuji Okusaka, Kohei Nakachi, Akira Fukutomi et al. · British Journal of Cancer · 2010 · 752 citations · Full text

, , +9

HIF‐1α induces cell cycle arrest by functionally counteracting Myc

Minori Koshiji, Yukio Kageyama, Erin A. Pete et al. · The EMBO Journal · 2004 · 647 citations · Full text

, , +14

1–5 of 50